Harbor Investment Advisory’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-659
| Closed | -$26.4K | – | 1368 |
|
|
2023
Q1 | $26.4K | Sell |
659
-214
| -25% | -$8.58K | ﹤0.01% | 857 |
|
|
2022
Q4 | $40.4K | Hold |
873
| – | – | 0.01% | 744 |
|
|
2022
Q3 | $36K | Hold |
873
| – | – | 0.01% | 775 |
|
|
2022
Q2 | $52K | Buy |
873
+118
| +16% | +$7.03K | 0.01% | 694 |
|
|
2022
Q1 | $55K | Hold |
755
| – | – | 0.01% | 726 |
|
|
2021
Q4 | $63K | Hold |
755
| – | – | 0.01% | 673 |
|
|
2021
Q3 | $68K | Hold |
755
| – | – | 0.01% | 638 |
|
|
2021
Q2 | $72K | Sell |
755
-75
| -9% | -$7.15K | 0.01% | 594 |
|
|
2021
Q1 | $95K | Sell |
830
-73
| -8% | -$8.36K | 0.01% | 493 |
|
|
2020
Q4 | $125K | Buy |
903
+153
| +20% | +$21.2K | 0.02% | 403 |
|
|
2020
Q3 | $62K | Buy |
750
+308
| +70% | +$25.5K | 0.01% | 445 |
|
|
2020
Q2 | $35K | Hold |
442
| – | – | 0.01% | 506 |
|
|
2020
Q1 | $20K | Buy |
+442
| New | +$20K | 0.01% | 578 |
|